Literature DB >> 25082736

Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.

Nadine C Olthof1, Christian U Huebbers, Jutta Kolligs, Mieke Henfling, Frans C S Ramaekers, Iris Cornet, Josefa A van Lent-Albrechts, Alexander P A Stegmann, Steffi Silling, Ulrike Wieland, Thomas E Carey, Heather M Walline, Susanne M Gollin, Thomas K Hoffmann, Johan de Winter, Bernd Kremer, Jens P Klussmann, Ernst-Jan M Speel.   

Abstract

HPV-related HNSCC generally have a better prognosis than HPV-negative HNSCC. However, a subgroup of HPV-positive tumors with poor prognosis has been recognized, particularly related to smoking, EGFR overexpression and chromosomal instability. Viral integration into the host genome might contribute to carcinogenesis, as is shown for cervical carcinomas. Therefore, all HPV16-positive HNSCC cell lines currently available have been carefully analyzed for viral and host genome parameters. The viral integration status, viral load, viral gene expression and the presence of aneusomies was evaluated in the cell lines UD-SCC-2, UM-SCC-047, UM-SCC-104, UPCI:SCC090, UPCI:SCC152, UPCI:SCC154 and 93VU147T. HPV integration was examined using FISH, APOT-PCR and DIPS-PCR. Viral load and the expression of the viral genes E2, E6 and E7 were determined via quantitative PCR. All cell lines showed integration-specific staining patterns and signals indicating transcriptional activity using FISH. APOT- and DIPS-PCR identified integration-derived fusion products in six cell lines and only episomal products for UM-SCC-104. Despite the observed differences in viral load and the number of viral integration sites, this did not relate to the identified viral oncogene expression. Furthermore, cell lines exhibited EGFR expression and aneusomy (except UPCI:SCC154). In conclusion, all HPV16-positive HNSCC cell lines showed integrated and/or episomal viral DNA that is transcriptionally active, although viral oncogene expression was independent of viral copy number and the number of viral integration sites. Because these cell lines also contain EGFR expression and aneusomy, which are parameters of poor prognosis, they should be considered suitable model systems for the development of new antiviral therapies.
© 2014 UICC.

Entities:  

Keywords:  APOT-PCR; DIPS-PCR; genetic localization; integration; viral integration

Mesh:

Substances:

Year:  2014        PMID: 25082736      PMCID: PMC5370555          DOI: 10.1002/ijc.29112

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  43 in total

1.  Interferon-beta treatment of cervical keratinocytes naturally infected with human papillomavirus 16 episomes promotes rapid reduction in episome numbers and emergence of latent integrants.

Authors:  M Trent Herdman; Mark R Pett; Ian Roberts; William O F Alazawi; Andrew E Teschendorff; Xiao-Yin Zhang; Margaret A Stanley; Nicholas Coleman
Journal:  Carcinogenesis       Date:  2006-09-14       Impact factor: 4.944

2.  High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.

Authors:  Marjon A de Boer; Ekaterina S Jordanova; Gemma G Kenter; Alexander A Peters; Willem E Corver; J Baptist Trimbos; Gert Jan Fleuren
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

3.  Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.

Authors:  Noor Gammoh; Helena Sterlinko Grm; Paola Massimi; Lawrence Banks
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas.

Authors:  J P Klussmann; S J Weissenborn; U Wieland; V Dries; J Kolligs; M Jungehuelsing; H E Eckel; H P Dienes; H J Pfister; P G Fuchs
Journal:  Cancer       Date:  2001-12-01       Impact factor: 6.860

5.  Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer.

Authors:  Niklas Reimers; Hans U Kasper; Soenke J Weissenborn; Hartmut Stützer; Simon F Preuss; Thomas K Hoffmann; Ernst Jan M Speel; Hans P Dienes; Herbert J Pfister; Orlando Guntinas-Lichius; Jens P Klussmann
Journal:  Int J Cancer       Date:  2007-04-15       Impact factor: 7.396

6.  Spectral karyotypic and comparative genomic analysis of the endocrine pancreatic tumor cell line BON-1.

Authors:  Juan R Lopez; Sandra M H Claessen; Merryn V E Macville; Jozefa C M Albrechts; Britt Skogseid; Ernst-Jan M Speel
Journal:  Neuroendocrinology       Date:  2009-10-29       Impact factor: 4.914

7.  Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line.

Authors:  Camille C Rose Ragin; Shalini C Reshmi; Susanne M Gollin
Journal:  Int J Cancer       Date:  2004-07-10       Impact factor: 7.396

8.  Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck.

Authors:  Walter J Koskinen; Ren Wei Chen; Ilmo Leivo; Antti Mäkitie; Leif Bäck; Risto Kontio; Riitta Suuronen; Christian Lindqvist; Eeva Auvinen; Anco Molijn; Wim G Quint; Antti Vaheri; Leena-Maija Aaltonen
Journal:  Int J Cancer       Date:  2003-11-10       Impact factor: 7.396

9.  A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.

Authors:  Harriet C Hafkamp; Ernst J M Speel; Annick Haesevoets; Fredrik J Bot; Winand N M Dinjens; Frans C S Ramaekers; Anton H N Hopman; Johannes J Manni
Journal:  Int J Cancer       Date:  2003-11-10       Impact factor: 7.396

10.  Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression.

Authors:  Nadine C Olthof; Ernst-Jan M Speel; Jutta Kolligs; Annick Haesevoets; Mieke Henfling; Frans C S Ramaekers; Simon F Preuss; Uta Drebber; Ulrike Wieland; Steffi Silling; Wan L Lam; Emily A Vucic; Bernd Kremer; Jens-P Klussmann; Christian U Huebbers
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

View more
  35 in total

Review 1.  Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.

Authors:  Farhoud Faraji; Munfarid Zaidi; Carole Fakhry; Daria A Gaykalova
Journal:  Microbes Infect       Date:  2017-06-12       Impact factor: 2.700

Review 2.  Human Papillomavirus Laboratory Testing: the Changing Paradigm.

Authors:  Eileen M Burd
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation ± Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis.

Authors:  Frank Ziemann; Andrea Arenz; Stefanie Preising; Claus Wittekindt; Jens P Klussmann; Rita Engenhart-Cabillic; Andrea Wittig
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

4.  Integrated Analysis of Whole-Genome ChIP-Seq and RNA-Seq Data of Primary Head and Neck Tumor Samples Associates HPV Integration Sites with Open Chromatin Marks.

Authors:  Dylan Z Kelley; Emily L Flam; Evgeny Izumchenko; Ludmila V Danilova; Hildegard A Wulf; Theresa Guo; Dzov A Singman; Bahman Afsari; Alyza M Skaist; Michael Considine; Jane A Welch; Elena Stavrovskaya; Justin A Bishop; William H Westra; Zubair Khan; Wayne M Koch; David Sidransky; Sarah J Wheelan; Joseph A Califano; Alexander V Favorov; Elana J Fertig; Daria A Gaykalova
Journal:  Cancer Res       Date:  2017-09-25       Impact factor: 12.701

5.  Identification of human papillomavirus (HPV) 16 DNA integration and the ensuing patterns of methylation in HPV-associated head and neck squamous cell carcinoma cell lines.

Authors:  Takashi Hatano; Daisuke Sano; Hideaki Takahashi; Hiroshi Hyakusoku; Yasuhiro Isono; Shoko Shimada; Kae Sawakuma; Kentaro Takada; Ritsuko Oikawa; Yoshiyuki Watanabe; Hiroyuki Yamamoto; Fumio Itoh; Jeffrey N Myers; Nobuhiko Oridate
Journal:  Int J Cancer       Date:  2017-01-09       Impact factor: 7.396

Review 6.  [HPV-associated oropharyngeal cancer-incidence, trends, diagnosis, and treatment].

Authors:  S Wagner; H Reder; S J Sharma; N Würdemann; C Wittekindt; J P Klußmann
Journal:  Urologe A       Date:  2018-12       Impact factor: 0.639

7.  HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.

Authors:  Lada A Koneva; Yanxiao Zhang; Shama Virani; Pelle B Hall; Jonathan B McHugh; Douglas B Chepeha; Gregory T Wolf; Thomas E Carey; Laura S Rozek; Maureen A Sartor
Journal:  Mol Cancer Res       Date:  2017-09-19       Impact factor: 5.852

8.  HPV status is associated with altered PIWI-interacting RNA expression pattern in head and neck cancer.

Authors:  Natalie Firmino; Victor D Martinez; David A Rowbotham; Katey S S Enfield; Kevin L Bennewith; Wan L Lam
Journal:  Oral Oncol       Date:  2016-02-04       Impact factor: 5.337

9.  Patients with integrated HPV16 in head and neck cancer show poor survival.

Authors:  Tara J Nulton; Nak-Kyeong Kim; Laurence J DiNardo; Iain M Morgan; Brad Windle
Journal:  Oral Oncol       Date:  2018-03-30       Impact factor: 5.337

10.  Genomic Integration of High-Risk HPV Alters Gene Expression in Oropharyngeal Squamous Cell Carcinoma.

Authors:  Heather M Walline; Christine M Komarck; Jonathan B McHugh; Emily L Bellile; J Chad Brenner; Mark E Prince; Erin L McKean; Douglas B Chepeha; Gregory T Wolf; Francis P Worden; Carol R Bradford; Thomas E Carey
Journal:  Mol Cancer Res       Date:  2016-07-15       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.